# A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

> **NCT06150560** · PHASE3 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 120 (estimated)

## Conditions studied

- Coarctation of Aorta
- High Blood Pressure

## Interventions

- **DRUG:** Losartan
- **DRUG:** Amlodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06150560
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06150560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06150560, "A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06150560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*